PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-70.15%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-60.19%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-145.06%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-176.21%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-205.44%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-204.18%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-204.18%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-88.28%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-88.28%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-47.59%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
100.00%
OCF/share CAGR of 100.00% while 6617.T is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
100.00%
OCF/share CAGR of 100.00% while 6617.T is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
No Data
No Data available this quarter, please select a different quarter.
94.08%
Positive 10Y CAGR while 6617.T is negative. John Neff might see a substantial advantage in bottom-line trajectory.
94.08%
Positive 5Y CAGR while 6617.T is negative. John Neff might view this as a strong mid-term relative advantage.
71.55%
Positive short-term CAGR while 6617.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
179.77%
Positive short-term equity growth while 6617.T is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.60%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
89.37%
Inventory growth well above 6617.T's 17.07%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
24.71%
Positive asset growth while 6617.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-0.96%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
96.39%
We have some new debt while 6617.T reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-10.08%
We cut SG&A while 6617.T invests at 124.25%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.